Assessment of the Fractures Risk in Patients with Nephrolithiasis

European Wellness researchers and collaborators have just published an important new study in SSP Modern Pharmacy and Medicine – revealing a hidden link between kidney stone disease and bone health that standard bone density tests might miss!

Here’s What It’s About:

✅ The research team studied 80 patients to understand how kidney stone disease (nephrolithiasis) affects fracture risk

✅ Standard bone mineral density (BMD) tests showed no difference between patients with and without kidney stones

✅ However, the Trabecular Bone Score (TBS) – which measures bone quality and microarchitecture – was significantly lower in kidney stone patients

✅ When TBS was factored into the 10-year fracture risk calculation, patients with kidney stones showed a notably higher risk of fractures

This means traditional bone density scans alone may not tell the full story for people with kidney stone disease.

💡 Why This Matters:

Kidney disease can disrupt vitamin D metabolism and trigger secondary hyperparathyroidism – a double threat that affects both stone formation and bone integrity. By incorporating TBS into fracture risk assessments, clinicians can identify at-risk patients earlier and begin preventive therapy sooner – potentially avoiding life-altering fractures down the road.

MORE PUBLICATIONS:
https://european-wellness.eu/publications/